Suboxone Antitrust Settlement

Settlement Structure: Claims Made

Active: Open

Case Summary:

Reckitt Benckiser Group plc is settling a Federal Trade Commission (FTC) antitrust action against it for $60 million. Suboxone is used to treat opioid addiction. The complaint alleged that the company tried to retain its market and thwart the makers of generics in order to keep its monopoly. According to the complaint, it tried to work a “product hopping” scheme, developing an oral film and trying to get prescribers to switch to it with the claim that it was safer because children were less likely to be exposed to it.

Docket Number:

1:19CV00028

Company: Reckitt Benckiser Group plc

Filing Deadline: December 1, 2020

Class Period: March 1, 2013 to February 28, 2019

Proof of Purchase:

You do not need to provide supporting documents at this time. However, you may be asked for more information later. Please retain whatever related documents you have.

Eligibility:

You may be eligible if you were prescribed Suboxone film in the US between March 1, 2013 and February 28, 2019.

Typical Settlement Amount:

Final amounts will depend on several factors, such as the length of time you were taking Suboxone and how many valid claims are received.

Total Settlement Amount: $60 million

Class Representative Proposed Incentive Fee:

Law Firm:
Federal Trade Commission

Claim Form: Suboxone Antitrust Settlement Claim Form

Case Name: Federal Trade Commission, Plaintiff, v. Reckitt Benckiser Group PLC, Defendant

Settlement Website: Suboxone Antitrust Settlement Website

Claims Administrator:
JND Legal Administration

Claims Administrator Contact Information:

Suboxone Claims Center
c/o JND Legal Administration
P.O. Box 91356
Seattle, WA 98111
Info@SuboxoneClaimsCenter.com
1‑877‑545‑0238

Tags: Antitrust, Pharmaceuticals